These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32126127)

  • 21. Re-evaluation of serum leptin and adiponectin concentrations normalized by body fat mass in patients with rheumatoid arthritis.
    Chihara K; Hattori N; Ichikawa N; Matsuda T; Saito T
    Sci Rep; 2020 Sep; 10(1):15932. PubMed ID: 32985609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
    Kizaki K; Yamashita F; Hayashi T; Funakoshi N
    Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
    Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
    Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Vaspin Levels Are Associated with the Development of Clinically Manifest Arthritis in Autoantibody-Positive Individuals.
    Maijer KI; Neumann E; Müller-Ladner U; Drop DA; Ramwadhdoebe TH; Choi IY; Gerlag DM; de Hair MJ; Tak PP
    PLoS One; 2015; 10(12):e0144932. PubMed ID: 26670468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the link between disease activity and infliximab serum levels in rheumatoid arthritis patients.
    Valor L; Hernández-Flórez D; de la Torre I; Del Río T; Nieto JC; González C; López-Longo FJ; Monteagudo I; Llinares F; Rosas J; Garrido J; Naredo E; Carreño L
    Clin Exp Rheumatol; 2015; 33(6):805-11. PubMed ID: 26314759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis.
    Yoshino T; Kusunoki N; Tanaka N; Kaneko K; Kusunoki Y; Endo H; Hasunuma T; Kawai S
    Intern Med; 2011; 50(4):269-75. PubMed ID: 21325757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leptin and adiponectin as predictors of disease activity in rheumatoid arthritis.
    Xibillé-Friedmann DX; Ortiz-Panozo E; Bustos Rivera-Bahena C; Sandoval-Ríos M; Hernández-Góngora SE; Dominguez-Hernandez L; Montiel-Hernández JL
    Clin Exp Rheumatol; 2015; 33(4):471-7. PubMed ID: 25936395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum leptin levels in rheumatoid arthritis and relationship with disease activity.
    Gunaydin R; Kaya T; Atay A; Olmez N; Hur A; Koseoglu M
    South Med J; 2006 Oct; 99(10):1078-83. PubMed ID: 17100028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
    Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
    J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction.
    Ebina K; Fukuhara A; Ando W; Hirao M; Koga T; Oshima K; Matsuda M; Maeda K; Nakamura T; Ochi T; Shimomura I; Yoshikawa H; Hashimoto J
    Clin Rheumatol; 2009 Apr; 28(4):445-51. PubMed ID: 19085030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline adiponectin and leptin levels in predicting an increased risk of disease activity in rheumatoid arthritis: A meta-analysis and systematic review.
    Cao H; Lin J; Chen W; Xu G; Sun C
    Autoimmunity; 2016 Dec; 49(8):547-553. PubMed ID: 27690205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors.
    Ngeuleu A; Allali F; Medrare L; Madhi A; Rkain H; Hajjaj-Hassouni N
    Rheumatol Int; 2017 Jun; 37(6):1015-1020. PubMed ID: 28258473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between Overweight/Obesity and Clinical Activity in Rheumatoid Arthritis.
    Alvarez-Nemegyei J; Pacheco-Pantoja E; González-Salazar M; López-Villanueva RF; May-Kim S; Martínez-Vargas L; Quintal-Gutiérrez D
    Reumatol Clin (Engl Ed); 2020; 16(6):462-467. PubMed ID: 30583870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug survival rates of biological disease-modifying antirheumatic drugs and Janus kinase-inhibitor therapy in 801 rheumatoid arthritis patients: a 14 year-retrospective study from a rheumatology clinic in Japan.
    Kondo M; Yamada H
    Mod Rheumatol; 2019 Nov; 29(6):928-935. PubMed ID: 30334661
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis.
    Senolt L; Pavelka K; Housa D; Haluzík M
    Cytokine; 2006 Sep; 35(5-6):247-52. PubMed ID: 17079158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease-modifying antirheumatic drugs increase serum adiponectin levels in patients with rheumatoid arthritis.
    Cansu B; Cansu DU; Kaşifoğlu T; Gülbas Z; Korkmaz C
    J Clin Rheumatol; 2011 Jan; 17(1):14-7. PubMed ID: 21169855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib.
    Bird P; Hall S; Nash P; Connell CA; Kwok K; Witcombe D; Thirunavukkarasu K
    RMD Open; 2019; 5(1):e000742. PubMed ID: 30886732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between anthropometric status and rheumatoid arthritis. Exploring the role of nesfatin and asymmetric dimethylarginine.
    Naghashian F; Hosseinzadeh-Attar MJ; Akhlaghi M; Yekaninejad MS; Aryaeian N; Derakhshanian H
    Acta Reumatol Port; 2019; 44(2):126-131. PubMed ID: 31280277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
    Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
    Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum vitamin D level and disease activity in patients with recent onset rheumatoid arthritis.
    Zakeri Z; Sandoughi M; Mashhadi MA; Raeesi V; Shahbakhsh S
    Int J Rheum Dis; 2016 Apr; 19(4):343-7. PubMed ID: 24134402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.